Outrageous FDA Delay Endangers Melanoma Victims

MelaFind®, is a a multi-spectral camera combined with sophisticated algorithms and software that images a potentially cancerous melanoma lesion. The image is then compared against a database of more than 10,000 biopsied lesions and 600 confirmed melanomas to provide a dermatologist with an immediate reading which can then be used to determine treatment options if the lesion is considered cancerous. This method of melanoma detection is in contrast to the commonly used method of diagnosing lesions based primarily on a doctor's estimate if a mole or lesion may be cancerous or not.